TASK-002: Bioequivalence of Bedaquiline 400mg Administered in Crushed Form Compared to Tablet Form in Healthy Male and Female Adults Under Fed Conditions (BDQ Crush Study)

Trial Profile

TASK-002: Bioequivalence of Bedaquiline 400mg Administered in Crushed Form Compared to Tablet Form in Healthy Male and Female Adults Under Fed Conditions (BDQ Crush Study)

Completed
Phase of Trial: Phase 0

Latest Information Update: 27 Jun 2018

At a glance

  • Drugs Bedaquiline (Primary)
  • Indications Tuberculosis
  • Focus Pharmacokinetics
  • Acronyms BDQ Crush Study
  • Most Recent Events

    • 27 Jun 2018 Primary endpoint has not been met. (Bioequivalence of bedaquiline 4 x 100mg given to healthy adult males and females orally in tablet form compared to crushed form)
    • 27 Jun 2018 Results published in the British Journal of Clinical Pharmacology
    • 20 Feb 2017 Status changed to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top